28 jun: Når lav risiko giver højt afkast
17 jul: Test
29-06-2012 07:30:51

Regulated information - Ageas communicates on revised total number of issued shares

Relateret indhold
28 aug - 
Mandagens aktier: Optur til Genmab og Novo gav status q..
28 aug - 
Mandagens aktier: Optur til Genmab og Novo gav status q..
28 aug - 
Euroinvestors bundlinje ramt af nedskrivninger og laver..

Following the cancellation of the shares bought back during the buy-back programme launched in August 2011, the total number of issued shares (the 'denominator') has fallen to 2,431,212,726.

At the end of January Ageas completed its share buy-back programme for a total amount of EUR 250 million, representing 192,168,091 shares. The General Meetings of Shareholders already approved at the end of April 2012 the cancellation of these shares but the Dutch law allows for a 2 month period of objection. As this period is now at an end, the shares have been cancelled, and as a result, the total amount of issued shares is reduced to 2,431,212,726. As from today, this number will be used to calculate percentage shareholdings.

As a further consequence, and in accordance with the rules on financial transparency, Ageas confirms that its interest fell below the threshold of 3% on 29 June 2012.

The transparency information is available on the Ageas website under "Investor relations - The share - Transparency requirements" (http://www.ageas.com/en/Pages/transparency_requirements.aspx). 

Ageas is an international insurance company with a heritage spanning more than 180 years. Ranked among the top 20 insurance companies in Europe, Ageas has chosen to concentrate its business activities in Europe and Asia, which together make up the largest share of the global insurance market. These are grouped around four segments: Belgium, United Kingdom, Continental Europe and Asia and served through a combination of wholly owned subsidiaries and partnerships with strong financial institutions and key distributors around the world. Ageas operates successful partnerships in Belgium, UK, Luxembourg, Italy, Portugal, Turkey, China, Malaysia, India and Thailand and has subsidiaries in France, Hong Kong and UK. It is the market leader in Belgium for individual life and employee benefits, as well as a leading non-life player, through AG Insurance, and in the UK, it has a strong presence as the third largest player in private car insurance and the over 50's market. It employs more than 13,000 people and has annual inflows of more than EUR 17 billion.

MEDIA CONTACT

+32 (0)2 557 57 37 / +32 (0) 479 79 50 02

INVESTOR RELATIONS

Brussels

+32 (0)2 557 57 33

Utrecht

+31 (0)30 252 53 05

Ageas

Rue du Marquis 1 - 1000 Brussels - Belgium

Archimedeslaan 6 - 3584 BA Utrecht - The Netherlands

www.ageas.com

Notification

Pdf version press release


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Ageas via Thomson Reuters ONE

HUG#1622732

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
09:39
EI
Er det ikke bare at sætte den i stikkontakten? Sådan virker vores ihvertfald
4
10:52
EI
Præcedans, 6212. - Er det en Nilfiskepolka?
2
10:11
EI
6212, det er en farlig udvikling, du har gang i. At du, som mand spørger konen, hvordan en støvsuger..
1

Nye digitale betalingsløsninger bryder frem

25-09-2017 08:45:00
Sponsoreret indhold:Af Jens Damgaard, Country Manager, Visa DenmarkEfter 20 år, hvor danskerne har taget imod ganske mange nye løsninger indenfor elektroniske/digitale betalinger, går udviklingen nu endnu hurtigere, og det gør Danmark til et af de mest avancerede betalingsmarkeder i Europa. Avanceret, fordi danskerne er parat til at bruge næsten enhver tænkelig mobil enhed til at betale med.Buti..

Novo: Fiasp godkendt i USA

29-09-2017 16:20:48
De amerikanske sundhedsmyndigheder, FDA, har godkendt Fiasp (hurtigtvirkende insulin aspart), en ny hurtigtvirkende måltidsinsulin, til behandling af voksne med diabetes.Det oplyser Novo Nordisk.FDA's beslutning kommer, efter at kliniske studier har dokumenteret, at Fiasp giver fordele for mennesker, der har behov for en forbedret generel blodsukkerregulering.- Vi er meget glade for, at Fiasp nu o..

Atlantic Petroleum: Direktør fratræder 1. december

29-09-2017 14:02:37
Topchefen for Atlantic Petroleum, der er noteret i Norge og København, direktør Ben Arabo, har opsagt sit job for at tiltræde et andet job på Færøerne.Det oplyser selskabet.Han vil dog blive hos Atlantic Petroleum til 1. december./ritzau/FINANSClaus Mikkelsen +45 33 30 03 35 Ritzau Finans, E-mail: finans@ritzau.dk , www.ritzaufinans.dk

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo: FDA-nyt sendte 37 mia. kr. i lommen på aktionærerne
2
Aktier/tendens: Kursmålsstorm over de danske aktier
3
Pandora/RBC: Tredje kvartal ses som "skæbnens time" - NY
4
Novo: Skæbnen for mulig milliardsællert er i eksperternes hænder
5
Pandora/RBC: Snitter næsten 17 pct. af kursmålet

Relaterede aktiekurser

Ageas 40,52 0,7% Stigning i aktiekurs
Euroinvestor.com A/S 9,50 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
17. oktober 2017 15:04:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171012.1 - EUROWEB7 - 2017-10-17 15:04:33 - 2017-10-17 15:04:33 - 1 - Website: OKAY